[This corrects the article DOI: 10.3389/fneur.2020.578924.].
Keywords: Parkinson's disease (PD); dopamine agonists; impulse control disorder; longitudinal analysis; risk factors.
Copyright © 2021 Binck, Pauly, Vaillant, Hipp, Gantenbein, Krueger and Diederich.